Nuclear Decommissioning Services Market is driven by
growing demand for electricity

The nuclear decommissioning services market involves
activities to safely dismantle or decontaminate nuclear facilities. It provides
dismantling, demolition and waste management services of retired nuclear power
plants and research reactors. Nuclear decommissioning slows down the growth of
radioactive inventory and clears the site for other uses. It helps reduce
operational and maintenance costs of abandoned nuclear facilities. The services
deal with decommissioning strategy planning, radiological characterization,
dismantling and segmentation, transportation and storage of radioactive waste.

Global Nuclear
Decommissioning Services Market is estimated to be valued at US$ 230.1 Mn in
2024 and is expected to exhibit a CAGR of 5.5% over the forecast period 2024 To
2031.



Key Takeaways

Key players operating in the nuclear decommissioning services are Advanced Cell
Technology, Inc., Angel Biotechnology Holdings PLC, Biotricity, Lineage Cell
Therapeutics, Inc., BrainStorm Cell Limited., CIRM, Celgene Corporation (A
subsidiary of Bristol-Myers Squibb Company), Takara Bio Inc., Cellular
Engineering Technologies., Cytori Therapeutics Inc., and STEMCELL Technologies.

Growing for clean and safe sources of energy generation is
expected to drive the Nuclear
Decommissioning Services Market Growth during the forecast period. With
rising number of retiring nuclear power plants, demand for nuclear
decommissioning services is anticipated to increase significantly over the
coming years. Several countries worldwide are undertaking large nuclear
decommissioning projects which is further expected to accelerate the market
expansion on the global level.

Get More
Insights on- Nuclear
Decommissioning Services Market